A condition that temporarily causes heart failure in people who experience severe stress might actually protect the heart by stopping the organ being pumped with too much adrenaline, a new study has revealed.
The research provides the first physiological explanation for Takotsubo cardiomyopathy, also called “broken heart syndrome” because it affects people who suffer severe emotional stress after bereavement, and suggests guidance for treatment.
Around 1-2 percent of people who are initially suspected of having a heart attack are finally discovered to have this increasingly recognised syndrome.
The Imperial College London study, which simulated the condition in an animal model, suggests that the body changes its response to adrenaline by switching from its usual role in stimulating the heart to reducing its pumping power.
Although this results in acute heart failure, most patients make a full recovery within days or weeks.
The researchers propose that the switch in the heart’s response to adrenaline might have evolved to protect the heart from being overstimulated by the particularly high doses of adrenaline that the body releases during stress.
Patients with Takotsubo cardiomyopathy, most often older women, experience symptoms that resemble a heart attack, but heart tests reveal no blockage in the coronary arteries.
Instead, the heart has a balloon-like appearance caused by the bottom of the heart not contracting properly.
The same condition is sometimes seen in people who are injected with adrenaline to treat severe allergic reactions.
In this new research, the authors simulated the condition by injecting high doses of adrenaline in anaesthetised rats. In these rats, as in Takotsubo patients, heart muscle contraction was suppressed towards the bottom of the heart.
They found that these rats were protected from an otherwise fatal overstimulation of the heart, indicating that adrenaline acts through a different pathway from usual, and that this switch protects the heart from toxic levels of adrenaline.
The study also examined drugs that might be useful for treating Takotsubo cardiomyopathy.
Some beta blockers, used to treat high blood pressure, angina and heart failure, reproduced or enhanced the features of Takotsubo, giving new insights into the protective effects of these drugs.
Levosimendan, a different type of drug given in heart failure to stimulate the heart without going through the adrenaline receptor pathways, had a beneficial effect.
“Adrenaline’s stimulatory effect on the heart is important for helping us get more oxygen around the body in stressful situations, but it can be damaging if it goes on for too long,” Sian Harding, the study leader from the National Heart and Lung Institute (NHLI) at Imperial College London, said.
“In patients with Takotsubo cardiomyopathy, adrenaline works in a different way and shuts down the heart instead. This seems to protect the heart from being overstimulated,” Harding added.
The study has been published in the journal Circulation.